Last week, New Delhi-based Ranbaxy pleaded guilty in the United States to charges of making and distributing adulterated drugs made at its two Indian plants of Paonta Sahib and Dewas, agreeing to a $500 million settlement.
Nearly 2,000 organizations from 22 countries provided input to the initial release of findings, which focused on the use of core quality practices.
Ranbaxy pleaded guilty to seven counts of felony after it distributed several India-produced adulterated generic drugs in the U.S. in 2005-2006.
"In our company, we have production people and we have quality people," Selleck explained in his keynote address at the IW Best Plants conference on Tuesday. "What makes us strong is that at Michelin, the quality people are kings...
The products, which are sold under the Hero Nutradefense label, have remained widely available in Chinese shops.
Dreamliner travels for two hours in a test flight that 'went according to plan.'
Every production line experiences trouble from time to time, but recurring mistakes are inexcusable.